252 related articles for article (PubMed ID: 25009280)
1. Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study.
Lu CH; Petzold A; Topping J; Allen K; Macdonald-Wallis C; Clarke J; Pearce N; Kuhle J; Giovannoni G; Fratta P; Sidle K; Fish M; Orrell R; Howard R; Greensmith L; Malaspina A
J Neurol Neurosurg Psychiatry; 2015 May; 86(5):565-73. PubMed ID: 25009280
[TBL] [Abstract][Full Text] [Related]
2. Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS.
Lu CH; Petzold A; Kalmar B; Dick J; Malaspina A; Greensmith L
PLoS One; 2012; 7(7):e40998. PubMed ID: 22815892
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study.
Gagliardi D; Faravelli I; Meneri M; Saccomanno D; Govoni A; Magri F; Ricci G; Siciliano G; Pietro Comi G; Corti S
J Cell Mol Med; 2021 Apr; 25(8):3765-3771. PubMed ID: 33609080
[TBL] [Abstract][Full Text] [Related]
4. Humoral response to neurofilaments and dipeptide repeats in ALS progression.
Puentes F; Lombardi V; Lu CH; Yildiz O; Fratta P; Isaacs A; Bobeva Y; Wuu J; ; ; Benatar M; Malaspina A
Ann Clin Transl Neurol; 2021 Sep; 8(9):1831-1844. PubMed ID: 34318620
[TBL] [Abstract][Full Text] [Related]
5. Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.
Halbgebauer S; Steinacker P; Verde F; Weishaupt J; Oeckl P; von Arnim C; Dorst J; Feneberg E; Mayer B; Rosenbohm A; Silani V; Ludolph AC; Otto M
J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):68-74. PubMed ID: 34417339
[TBL] [Abstract][Full Text] [Related]
6. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.
Lu CH; Macdonald-Wallis C; Gray E; Pearce N; Petzold A; Norgren N; Giovannoni G; Fratta P; Sidle K; Fish M; Orrell R; Howard R; Talbot K; Greensmith L; Kuhle J; Turner MR; Malaspina A
Neurology; 2015 Jun; 84(22):2247-57. PubMed ID: 25934855
[TBL] [Abstract][Full Text] [Related]
7. Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis.
Puentes F; Topping J; Kuhle J; van der Star BJ; Douiri A; Giovannoni G; Baker D; Amor S; Malaspina A
J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):274-8. PubMed ID: 24078718
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
[TBL] [Abstract][Full Text] [Related]
9. Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis.
Steinacker P; Fang L; Kuhle J; Petzold A; Tumani H; Ludolph AC; Otto M; Brettschneider J
PLoS One; 2011; 6(8):e23600. PubMed ID: 21858182
[TBL] [Abstract][Full Text] [Related]
10. A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry.
Zucchi E; Lu CH; Cho Y; Chang R; Adiutori R; Zubiri I; Ceroni M; Cereda C; Pansarasa O; Greensmith L; Malaspina A; Petzold A
J Neurochem; 2018 Sep; 146(5):631-641. PubMed ID: 29959860
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis.
Li S; Ren Y; Zhu W; Yang F; Zhang X; Huang X
J Neurol Sci; 2016 Aug; 367():269-74. PubMed ID: 27423602
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net.
Steinacker P; Huss A; Mayer B; Grehl T; Grosskreutz J; Borck G; Kuhle J; Lulé D; Meyer T; Oeckl P; Petri S; Weishaupt J; Ludolph AC; Otto M
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):112-119. PubMed ID: 27819158
[TBL] [Abstract][Full Text] [Related]
13. Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion.
Benatar M; Wuu J; Andersen PM; Lombardi V; Malaspina A
Ann Neurol; 2018 Jul; 84(1):130-139. PubMed ID: 30014505
[TBL] [Abstract][Full Text] [Related]
14. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis.
Al-Chalabi A; Andersen PM; Nilsson P; Chioza B; Andersson JL; Russ C; Shaw CE; Powell JF; Leigh PN
Hum Mol Genet; 1999 Feb; 8(2):157-64. PubMed ID: 9931323
[TBL] [Abstract][Full Text] [Related]
15. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
Gille B; De Schaepdryver M; Goossens J; Dedeene L; De Vocht J; Oldoni E; Goris A; Van Den Bosch L; Depreitere B; Claeys KG; Tournoy J; Van Damme P; Poesen K
Neuropathol Appl Neurobiol; 2019 Apr; 45(3):291-304. PubMed ID: 29908069
[TBL] [Abstract][Full Text] [Related]
16. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
[TBL] [Abstract][Full Text] [Related]
17. Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis.
McCombe PA; Pfluger C; Singh P; Lim CY; Airey C; Henderson RD
J Neurol Sci; 2015; 353(1-2):122-9. PubMed ID: 25958264
[TBL] [Abstract][Full Text] [Related]
18. Plasma NfL levels and longitudinal change rates in
Saracino D; Dorgham K; Camuzat A; Rinaldi D; Rametti-Lacroux A; Houot M; Clot F; Martin-Hardy P; Jornea L; Azuar C; Migliaccio R; Pasquier F; Couratier P; Auriacombe S; Sauvée M; Boutoleau-Bretonnière C; Pariente J; Didic M; Hannequin D; Wallon D; ; ; Colliot O; Dubois B; Brice A; Levy R; Forlani S; Le Ber I
J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1278-1288. PubMed ID: 34349004
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid MFG-E8 as a promising biomarker of amyotrophic lateral sclerosis.
Yang B; Wu Y; Wang Y; Yang H; Du B; Di W; Xu X; Shi X
Neurol Sci; 2020 Oct; 41(10):2915-2920. PubMed ID: 32338335
[TBL] [Abstract][Full Text] [Related]
20. Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis.
Thouvenot E; Demattei C; Lehmann S; Maceski-Maleska A; Hirtz C; Juntas-Morales R; Pageot N; Esselin F; Alphandéry S; Vincent T; Camu W
Eur J Neurol; 2020 Feb; 27(2):251-257. PubMed ID: 31437330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
